A lifetime oncogenicity study in rats with acrylamide

Toxicological Sciences

Volumn 27, Issue 1, 1995, Pages 95-105

  Friedman, Marvin A ^a   Dulak, Linda H ^b   Stedham, Michael A ^c  

^a CYTEC INDUSTRIES INC   (United States)

^b LHD Consulting   (United States)

^c CHARLES RIVER LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACRYLAMIDE;

ADENOCARCINOMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST TUMOR; CARCINOGENICITY; CONTROLLED STUDY; FEMALE; FIBROADENOMA; HISTOPATHOLOGY; MALE; MESOTHELIOMA; NEUROTOXICITY; NONHUMAN; PAPILLOMA; RAT; SCIATIC NERVE; TESTIS CANCER; THYROID TUMOR;

ANIMALIA;

EID: 77957179358     PISSN: 10966080     EISSN: None     Source Type: Journal    
DOI: 10.1093/toxsci/27.1.95     Document Type: Article

References (55)

1. Armitage, P. (1955). Tests for linear trends in proportions and frequencies. Biometrics 11, 375-386.
2. Berman, J. J., and Rice, J. M. (1979). Mesotheliomas and proliferative lesions of the testicular mesothelium produced in Fischer, Sprague-Dawley and Buffalo rats by methy](acetoxymethyl)nitrosamine (DMN-OAc). Vet. Pathol 16, 574-582.
3. Bikales, N. M. (1973). Preparation of acrylamide polymers. In Water-Soluble Polymers. Polymer Science and Technology Series., Vol 2 (N. M. Bikales. Ed.), pp. 214-225. Plenum. New York.
4. Bull, R. J., Robinson, M., Laurie, R. D., Stoner, G. D., Grcisiger, E., Meier. J. R., and Stober, J. (1984a). Carcinogenic effects of acrylamide in sencar and A/J mice. Cancer Res 44, 107-111.
5. Bull, R. J., Robinson, M., and Stober J. A. (1984b). Carcinogenic activity of acrylamide in the skin and lung of Swiss-ICR mice. Cancer Lett., 24, 209-212.
6. Burek, J. C., Albee, R. R., Beyer, J. E., Bell, T. J., Carreon, R. M., Morden, D. C., Wade, C. E., Hermann, E. A., and Gorzinski, S. J. (1980). Subchronic toxicity of acrylamide administered to rats in the drinking water followed by up to 144 days of recovery. J Environ. Pathol Toxicol., 4, 157-182.
7. Carlson, G. P., Fossa, A. A., Morse, M. A., and Weaver, P. M. (1986). Binding and distribution studies in the SENCAR mouse of compounds demonstrating a route-dependent tumorigenic effect. Environ Health Perspect., 68, 53-60.
8. 2 test. Biometrics 10, 417-451.
9. Collins, J. J., Swaen, G. M. H., Marsh, G. M., Utidjian, H. M. D., Caporossi, J. C., and Lucas, L. J. (1989). Mortality patterns among workers exposed to acrylamide. J. Occup. Med., 31 (in press).
10. Conway, E. J., Peterson, R. J., Colingersworth, R. F., Graca, J. G., and Carter, J. W. (1979). Assessment of the need for and character of limitations on acrylamide and its compounds. Draft report prepared for the Office of Pesticides ant Toxic Substances., Contract № 68-01-4308. U.S. Environmental Protection Agency, Washington, DC.
11. Dinse, G. E., and Lagakos, S. W. (1983). Regression analysis of tumour prevalence data. Appl. Slat., 32, 236-248.
12. Flock, H. G., and Rasch, E. G. (1973). Application of polyelectrolytes in municipal waste treatment. In Water-Soluble Polymers, Polymer Science and Technology Series, Vol. 2 (N. M. Bikales, Ed.), pp. 21-73. Plenum, New York.
13. Frankos, V. (1985). Critical review of acrylamide’s carcinogenic activity in Fischer 344 rats: Design of a new cancer bioassay in rats. Report to American Cyanamid from Environ. Corp., Washington, DC.
14. Fullerton, P. M., and Barnes, J. M. (1966). Peripheral neuropathy in rats produced by acrylamide. Br J Ind. Med., 23, 210-221.
15. Garman, R H. (1989). Malignant reticulosis, rat. In Nervous System, Monographs on Pathology of Laboratory Animats, pp. 117-123. Spnnger-Verlag, New York.
16. Goodman, D. G., Ward, J. M., Squire, R. A., Chu, K. C., and Linhart, M. S. (1979). Neoplastic and nonneoplastic lesions in aging F344 rats. Toxicol Appl. Pharmacol., 48, 237-248.
17. Haseman, J. K. (1983). NTP rodent control data base. NTP Technical Bulletin № 10, pp. 9-10.
18. Haseman, J. K., Huff, J., and Goorman, G. A. (1984). Use of historical control data in carcinogenicity studies in rodents. Toxicol. Pathol., 12, 126-135.
19. Howland, R., and Alii, P. (1986). Altered phosphorylation of rat neuronal cytoskeletal proteins in acrylamide induced neuropathy. Brain Res., 363, 333-339.
20. Johnson, K. A., Gorzinski, S. J., Bodner, K. M., Campbell, R. A., Wolf, C. H., Friedman, M. A., and Mast, R. W. (1986). Chronic toxicity and oncogenicity study on acrylamide incorporated in the drinking water of Fischer 344 rats. Toxicol. Appl. Pharmacol., 85, 154-168.
21. Kaplan, E. L., and Meier, P. (1958). Nonparametric estimation from incomplete observations. J Am. Stat. Assoc 53, 457-481.
22. Keefe, R. T. (1989). 28-Day subchronic dose toxicity study in rats. Draft report, Exxon Biomedical Sciences, Inc. Toxicology Laboratory, East Millstone. NJ.
23. Krinke, G., Naylor, D. C., Schmid, G., Frohlich, E., and Schnider, K. (1985). The incidence of naturally-occurring primary brain tumors in the laboratory rat. J Comp. Pathol., 95, 175-192.
24. 14C]acrylamide to neurofilament and microtubule proteins of rats. Brain Res 481, 157-161.
25. Lapadula, D. M., Carrington, C. D., Dulak, L., Friedman, M., and Abou-Donia, M. B. (1989b). Covalent binding of acrylamide to proteins in the mouse central nervous system in vivo. Toxicologist 9, 146.
26. Lijinsky, W., and Andrews, A. W. (1980). Mutagenicity of vinyl compounds in Salmonella lyphimurium. Teratog. Carcinog. Mutagen., 1, 259-267.
27. MacWilliams, D. C., Rodgers, J. H., and West, T. J. (1973). Water-soluble polymers in petroleum recovery. In Water-Soluble Polymers, Polymer Science and Technology Series, Vol 2 (N. M. Bikales, Ed.), pp. 21-73. Plenum, New York.
28. Mantel, N. (1966). Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother. Rep., 50, 163-170.
29. Martenson, C. H., Sheetz, M. P., and Graham, D. G. (1993). Effect of acrylamide on the activity of purified dynein and kineson. The Society of Toxicology Abstracts 1993 Annual Meeting. Toxicologist 13, 125.
30. McConnel, E. E., Solleveld, H. A., Givenberg, J. A., and Boorman, G. A. (1986). Guidelines for combining neoplasms for evaluation of rodent carcinogenesis studies. J. Nad. Cancer Inst., 76, 283-289.
31. National Institute for Occupational Safety and Health (NIOSH) (1976). Criteria for a recommended standard-Occupational exposure to acrylamide. DHEW 77-112. Washington, DC.
32. NTP (1985). National Toxicology Program Fiscal Year 1985 Annual Plan., National Toxicology Program (NTP), Public Health Service (PHS), USDHHS. Publication NTP-85-055.
33. Peto, R., Pike, M., Day, N., Gray, R., Lee, P., Parish, S., Peto, J., Richards, S., and Wahrendorf, J. (1980). Guidelines for simple sensitive, significance tests for carcinogenic effects in long-term animal experiments, annex to long-term and short-term screening assays for carcinogens: A critical appraisal. IARC monogr Suppl., 2, 311-426.
34. Pryor, G. T., Uyeno, E. T., Tilson, H. A., and Mitchell, C. L. (1983). Assessment of chemicals using a battery of neurobehavorial tests: A comparative study. Neurobehav. Toxicol. Teratol., 5, 91-117.
35. Robinson, M., Bull, R. J., Knutsen, G. L., Shields, R. P., and Stober, J. (1986). A combined carcinogen bioassay utilizing both the lung adenoma and skin papilloma protocols. Environ. Health Perspect., 68, 141-146.
36. Sager, P. R. (1989). Cytoskeletal effects of acrylamide and 2,5-hexanedione: Selective aggression of vimentin filaments. Toxicol. Appl Pharmacol., 97, 141-155.
37. Sass, B., Rabstein, L. S., Madison, R., Nims, R. M., Peters, R. L., and Kelloff, G. J. (1975). Incidence of spontaneous neoplasms in F344 rats throughout the natural life-span. J. Natl. Cancer Inst., 54, 1449-1456.
38. Schaumburg, H. H., Wisiewski, H. M., and Spencer, P. S. (1974). Ultrastructural studies of the dying-back process. I. Peripheral nerve terminal and axori degeneration in systemic acrylamide intoxication. J Neuropathol. Exp. Neurol., 33, 260-284.
39. Sega, G. A., Valdivia, R. P. A., and Brimer, P. A. (1988). Binding of acrylamide to spermiogenic stages in the mouse and its correlation with genetic damage. Environ. Mutagen., 11, (Suppl.), 92-93.
40. Shiraishi, Y. (1978). Chromosome aberrations induced by monomeric acrylamide in bone marrow and germ cells of mice. Mutation Res., 57, 313-324.
41. Sickles, D. W. (1989). Toxic neurofilamentous axonopathies and fast anterograde axonal transport. I. The effects of single doses of acrylamide on the rate and capacity of transport. Neurotoxicology 10, 91-102.
42. Sickles, D. W. (1991). Toxic neurofilamentous anonopathies and fast anterograde axonal transport. III. Recovery from single injections and multiple dosing effects of acrylamide and 2,5-hexanedione. Toxicol. Appl. Pharmacol., 108, 390-396.
43. Sickles, D. W., Pearson, J. K., Beall, A., and Testino, A. Toxic axonal degeneration occurs independent of neurofilament proteins., Submitted for publication.
44. Smith, M. K., Zenick, H., Preston, R., George, E., and Long, R. (1986). Dominent lethal effects of subchronic acrylamide administration in the male Long-Evans rat. Mutat. Res., 173, 273-277.
45. Sobel, W., Bond, G. G., Parsons, T. W., and Brenner, R. E. (1986). Acrylamide cohort mortality study. Br. J. Ind. Med., 43, 785-788.
46. Solleveld, H. A., Haseman, J. K., and McConnell, E. E. (1984). Natural history of body weight gain, survival, and neoplasia in the F344 rat. J. Nall Cancer Inst., 72, 929-940.
47. Solomon, J., Fedyk, J., Mukai, F., and Segal, A. (1985). Direct alkylation of 2'-deoxynucleosides and DNA following in vitro reaction with acrylamide. Cancer Res., 45, 3465-3470.
48. Spencer, P. S., and Schaumburg, H. H. (1974). A review of acrylamide neurotoxicity, Part I. Properties, uses and human exposures. Can J. Neurol Sci., 1, 143-150.
49. Tanigawa, H., Onodera, H., and Maekawa, A. (1987). Spontaneous mesotheliomas in Fischer rats-A histological and electron microscopic study. Toxicol. Pathol., 15, 157-163.
50. Tanii, H., and Hashimoto, K. (1983). Neurotoxicity of acrylamide and related compounds in rats. Effects on rotarod performance, morphology of nerves and neurotubulin. Arch. Toxicol., 54, 203.
51. Tarone, R. E. (1975). Tests for trend in life table analysis. Biometnka 62, 679-682.
52. Turek, F. W., and Desjardins, C. (1979). Development of Leydigcell tumors and onset of changes in the reproductive and endocrine systems of aging F344 rats. J. Natl. Cancer Inst., 63, 969-975.
53. U.S. Environmental Protection Agency (US EPA) (1976). Investigation of selected potential environmental contaminants; Acrylamides. EPA-560/2-76-008. Washington, DC.
54. Whitaker, D., Papadimitriou, J. M., and Walters, M. N-I. (1982). The mesothelium and its reactions: A review. Crit. Rev Toxicol 10, 81-144.
55. Zenick, H., Hope, E., and Smith, M. K. (1986). Reproductive toxicity associated with acrylamide treatment in male and female rats. J. Toxicol Environ. Health 17, 457-472.